Mahony Susan 4

What Happened

• Susan Mahony, a director of Assembly Biosciences (ASMB), was granted options covering 8,000 shares on 2026-06-04. The Form 4 reports the acquisition as a derivative grant at $0.00 (this reflects an option award, not a cash purchase or immediate sale). This is an award/option grant — not a sale — and does not represent exercised or sold shares.

Key Details

• Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely filing).
• Transaction type/code: A — Grant / award (derivative security: stock options).
• Shares/options granted: 8,000; acquisition price reported: $0.00 on Form 4.
• Shares owned after transaction: Not provided in the supplied excerpt of the filing.
• Footnote: Grant of stock options that vest, assuming continuous service, on the earlier of (1) June 4, 2027 and (2) the issuer’s 2027 annual meeting of stockholders.
• No indication in this filing that options were exercised or shares sold.

Context

• This was a derivative grant (stock options). Options give the holder the right to buy shares later subject to vesting and any exercise price; they are common compensation for executives and directors.
• Because the grant vests over time, it’s not an immediate purchase or sale and doesn’t by itself signal a near-term change in ownership. No exercise price or immediate sale information is included in the provided data.